• Issue

    British Journal of Haematology: Volume 156, Issue 1

    1-151
    January 2012
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Images in Haematology

Visceral leishmaniasis after alemtuzumab in a patient with chronic lymphocytic leukaemia

Vincenzo Pitini,  Antonio Cascio,  Carmela Arrigo,  Giuseppe Altavilla, 
  • Page: 1
  • First Published: 25 July 2011

Hypereosinophilia in relapsed acute myeloid leukaemia

Anna Colpo,  Daniel Boyer,  Amir T. Fathi, 
  • Page: 2
  • First Published: 02 August 2011

Reviews

Do proteolytic antibodies complete the panoply of the autoimmune response in acquired haemophilia A?

Ankit Mahendra,  Séverine Padiolleau-Lefevre,  Srinivas V. Kaveri,  Sébastien Lacroix-Desmazes, 
  • Pages: 3-12
  • First Published: 12 October 2011

Exploration of the pathogenesis of haemophilic joint arthropathy: understanding implications for optimal clinical management

Suchitra S. Acharya, 
  • Pages: 13-23
  • First Published: 03 November 2011

The pathogenesis and management of the coagulopathy of acute promyelocytic leukaemia

Karen A. Breen,  David Grimwade,  Beverley J. Hunt, 
  • Pages: 24-36
  • First Published: 03 November 2011

Guideline

Free Access

Guidelines for the diagnosis and management of hereditary spherocytosis – 2011 update

Paula H. B. Bolton-Maggs,  Jacob C. Langer,  Achille Iolascon,  Paul Tittensor,  May-Jean King, 
  • Pages: 37-49
  • First Published: 05 November 2011

Haematological Malignancy

Hodgkin lymphoma as Richter transformation in chronic lymphocytic leukaemia: a retrospective analysis of world literature

Bruno Bockorny,  Ion Codreanu,  Constantin A. Dasanu, 
  • Pages: 50-66
  • First Published: 24 October 2011

TET2 deletions are a recurrent but rare phenomenon in myeloid malignancies and are frequently accompanied by TET2 mutations on the remaining allele

Ulrike Bacher,  Sandra Weissmann,  Alexander Kohlmann,  Sonja Schindela,  Tamara Alpermann,  Susanne Schnittger,  Wolfgang Kern,  Torsten Haferlach,  Claudia Haferlach, 
  • Pages: 67-75
  • First Published: 24 October 2011

PRDM16 (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignancies

Francois P. Duhoux,  Geneviève Ameye,  Carmen P. Montano-Almendras,  Khadija Bahloula,  Marie J. Mozziconacci,  Sophy Laibe,  Iwona Wlodarska,  Lucienne Michaux,  Pascaline Talmant,  Steven Richebourg,  Eric Lippert,  Frank Speleman,  Christian Herens,  Stéphanie Struski,  Sophie Raynaud,  Nathalie Auger,  Nathalie Nadal,  Katrina Rack,  Francine Mugneret,  Isabelle Tigaud,  Marina Lafage,  Sylvie Taviaux,  Catherine Roche-Lestienne,  Dominique Latinne,  Jeanne M. Libouton,  Jean-Baptiste Demoulin,  Hélène A. Poirel,  on behalf of the Groupe Francophone de Cytogénétique Hématologique (GFCH) and of the Belgian Cytogenetic Group for Haematology and Oncology (BCG-HO) , 
  • Pages: 76-88
  • First Published: 03 November 2011

Paediatric

CD22 Exon 12 deletion is a characteristic genetic defect of therapy-refractory clones in paediatric acute lymphoblastic leukaemia

Hong Ma,  Sanjive Qazi,  Zahide Ozer,  Paul Gaynon,  Gregory H. Reaman,  Fatih M. Uckun, 
  • Pages: 89-98
  • First Published: 21 October 2011

Adenovirus infection in paediatric allogeneic stem cell transplantation recipients is a major independent factor for significantly increasing the risk of treatment related mortality

Diane George,  Nader Kim El-Mallawany,  Zhezhen Jin,  Mark Geyer,  Phyllis Della-Latta,  Prakash Satwani,  James H. Garvin,  Mary Brigid Bradley,  Monica Bhatia,  Carmella van de Ven,  Erin Morris,  Joseph Schwartz,  Mitchell S. Cairo, 
  • Pages: 99-108
  • First Published: 18 October 2011

Longitudinal analysis of antibody response to immunization in paediatric survivors after allogeneic haematopoietic stem cell transplantation

Hiroto Inaba,  Christine M. Hartford,  Deqing Pei,  Meredith J. Posner,  Jie Yang,  Randall T. Hayden,  Ashok Srinivasan,  Brandon M. Triplett,  Jon A. McCulllers,  Ching-Hon Pui,  Wing Leung, 
  • Pages: 109-117
  • First Published: 24 October 2011

Transplantation

Interactions between killer immunoglobulin-like receptors and their human leucocyte antigen Class I ligands influence the outcome of unrelated haematopoietic stem cell transplantation for thalassaemia: a novel predictive algorithm

Roberto Littera,  Nicola Orrù,  Giovanni Caocci,  Marco Sanna,  Marina Mulargia,  Eugenia Piras,  Adriana Vacca,  Claudio Giardini,  Maria G. Orofino,  Giuseppe Visani,  Alice Bertaina,  Giovanna Giorgiani,  Franco Locatelli,  Carlo Carcassi,  Giorgio La Nasa, 
  • Pages: 118-128
  • First Published: 14 November 2011

Correspondence

Free Access

Targeting PIM kinase activity significantly augments the efficacy of cytarabine

Kevin R. Kelly,  Claudia M. Espitia,  Pietro Taverna,  Gavin Choy,  Swaminathan Padmanabhan,  Steffan T. Nawrocki,  Francis J. Giles,  Jennifer S. Carew, 
  • Pages: 129-132
  • First Published: 21 June 2011
Free Access

Genetic variation at the 8q24 locus confers risk to multiple myeloma

Prerna Tewari,  Anthony W. Ryan,  Patrick J. Hayden,  Mark Catherwood,  Stephen Drain,  Anthony Staines,  Tim Grant,  Alexandra Nieters,  Nikolaus Becker,  Silvia de Sanjose,  Lenka Foretova,  Mark Maynardie,  Pierluigi Cocco,  Paolo Boffetta,  Paul Brennan,  Stephen Chanock,  Mark Lawler,  Paul V. Browne, 
  • Pages: 133-136
  • First Published: 19 July 2011
Free Access

Plasmablastic solitary plasmacytoma of bone expressing granulocyte colony-stimulating factor and its receptor

Shoko Nakayama-Ichiyama,  Taiji Yokote,  Kazuki Iwaki,  Yuji Hirata,  Motomu Tsuji,  Toshiaki Hanafusa, 
  • Page: 137
  • First Published: 18 July 2011
Free Access

Variant alleles of cytokine genes influence risk and clinical course of Langerhans cell histiocytosis

Thomas Lehrnbecher,  Emilia Salzmann-Manrique,  Jan Soerensen,  Karin Beutel,  Gritta Janka,  Helmut Gadner,  Milen Minkov, 
  • Pages: 138-141
  • First Published: 16 August 2011
Free Access

Autologous stem cell transplantation remains beneficial for patients relapsing after R-CHOP chemotherapy and who respond to salvage chemotherapy

Sally Moore,  Karl Peggs,  Kirsty Thomson,  Lisa Lowry,  Antonia Ljubic,  Anthony H. Goldstone,  David C. Linch,  Kirit M. Ardeshna, 
  • Pages: 142-143
  • First Published: 16 August 2011
Free Access

Secondary prophylaxis with warfarin for recurrent thrombosis in a patient with Glanzmann thrombasthenia and F5 G1691A

Suely Meireles Rezende, 
  • Page: 144
  • First Published: 16 August 2011
Free Access

Salvage therapy of Autoimmune Thrombocytopenic Purpura revealing non-Hodgkin Lymphoma by the thrombopoietin receptor agonist romiplostim

Chadi Al-Nawakil,  Sophie Park,  Nicolas Chapuis,  Francois Dreyfus,  Tali-Anne Szwebel,  Laure Gibault,  Thierry Molina,  Olivier Hermine,  Didier Bouscary,  Jerome Tamburini, 
  • Pages: 145-147
  • First Published: 16 August 2011
Free Access

Chronic lymphocytic leukaemia responsive to vitamin D administration

Jean-Benoît Arlet,  Céline Callens,  Olivier Hermine,  Luc Darnige,  Elisabeth Macintyre,  Jacques Pouchot,  Loïc Capron, 
  • Pages: 148-149
  • First Published: 25 August 2011
Free Access

Comment on Guidelines on oral anticoagulation with warfarin – 4th edition

Jivendra Gosai,  Rangasamy Muthusamy, 
  • Page: 150
  • First Published: 18 August 2011
Free Access

Comment on Guidelines on oral anticoagulation with warfarin – 4th edition. Response to Gosai & Muthusamy

David M. Keeling,  on behalf of the British Committee for Standards in Haematology , 
  • Page: 151
  • First Published: 25 August 2011